This week, there are 9 drugs in the patent and exclusivity list. They are: - GILEAD SCIENCES INC's ZYDELIG, containing active ingredient IDELALISIB - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STRIVERDI RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE - CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES 's LYMPHOSEEK KIT, containing active ingredient TECHNETIUM TC-99M TILMANOCEPT - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STIOLTO RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - CORMEDIX INC's DEFENCATH, containing active ingredient HEPARIN SODIUM; TAUROLIDINE - BIOMARIN PHARMACEUTICAL INC's KUVAN, containing active ingredient SAPROPTERIN DIHYDROCHLORIDE - MITSUBISHI TANABE PHARMA CORP's RADICAVA ORS, containing active ingredient EDARAVONE - DECIPHERA PHARMACEUTICALS LLC's QINLOCK, containing active ingredient RIPRETINIB Read More

This week, there are 12 drugs in the patent and exclusivity list. They are: - VIIV HEALTHCARE CO's RUKOBIA, containing active ingredient FOSTEMSAVIR TROMETHAMINE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STIOLTO RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's SPIRIVA RESPIMAT, containing active ingredient TIOTROPIUM BROMIDE - VIFOR PHARMA INC's VELTASSA, containing active ingredient PATIROMER SORBITEX CALCIUM - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - TEVA PHARMACEUTICAL INDUSTRIES LTD's AIRDUO RESPICLICK, containing active ingredient FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - PF PRISM CV's XALKORI, containing active ingredient CRIZOTINIB - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's JARDIANCE, containing active ingredient EMPAGLIFLOZIN Read More

This week, there are 7 drugs in the patent and exclusivity list. They are: - DURYSTA by AbbVie Inc, containing active ingredient Bimatoprost - IXEMPRA KIT by R-Pharm US LLC, containing active ingredient Ixabepilone - XIFAXAN by Salix Pharmaceuticals Inc, containing active ingredient Rifaximin - DIFFERIN by Galderma Laboratories LP, containing active ingredient Adapalene - NEXLIZET by Esperion Therapeutics Inc, containing active ingredient Bempedoic Acid; Ezetimibe ​- NEXLETOL by Esperion Therapeutics Inc, containing active ingredient Bempedoic Acid - XARELTO by Janssen Pharmaceuticals Inc, containing active ingredient Rivaroxaban Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - KYOWA KIRIN INC's NOURIANZ, containing active ingredient ISTRADEFYLLINE - SEAGEN INC's TUKYSA, containing active ingredient TUCATINIB - VANDA PHARMACEUTICALS INC's PONVORY, containing active ingredient PONESIMOD - AVEO PHARMACEUTICALS INC's FOTIVDA, containing active ingredient TIVOZANIB HYDROCHLORIDE - BIOMARIN PHARMACEUTICAL INC's KUVAN, containing active ingredient SAPROPTERIN DIHYDROCHLORIDE - PROVENSIS LTD's VARITHENA, containing active ingredient POLIDOCANOL - BEIGENE USA INC's BRUKINSA, containing active ingredient ZANUBRUTINIB - SHIONOGI INC's FETROJA, containing active ingredient CEFIDEROCOL SULFATE TOSYLATE Read More